References
- CurrieBJDanceDAChengACThe global distribution of Burkholderia pseudomallei and melioidosis: an updateTrans R Soc Trop Med Hyg2008102Suppl 1S1S419121666
- WuthiekanunVAmornchaiPSaipromNSurvey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast ThailandAntimicrob Agents Chemother201155115388539121876049
- JenneyAWLumGFisherDACurrieBJAntibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosisInt J Antimicrob Agents200117210911311165114
- ChengACCurrieBJMelioidosis: epidemiology, pathophysiology, and managementClin Microbiol Rev200518238341615831829
- SarovichDSPriceEPVon SchulzeATCharacterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from AustraliaPLoS One201272e3078922363490
- ChantratitaNRhollDASimBAntimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomalleiProc Natl Acad Sci U S A201110841171651717021969582
- SamICSeeKHPuthuchearySDVariations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomalleiJ Clin Microbiol20094751556155819297597
- KungCTLeeCHLiCJLuHIKoSFLiuJWDevelopment of ceftazidime resistance in Burkholderia pseudomallei in a patient experiencing melioidosis with mediastinal lymphadenitisAnn Acad Med Singapore2010391294594721274496
- BeheraBPrasad BabuTKamaleshAReddyGCeftazidime resistance in Burkholderia pseudomallei: first report from IndiaAsian Pac J Trop Med20125432933022449529
- HaydenHSLimRBrittnacherMJEvolution of Burkholderia pseudomallei in recurrent melioidosisPLoS One201275e3650722615773
- TribuddharatCMooreRABakerPWoodsDEBurkholderia pseudomallei class A β-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibitionAntimicrob Agents Chemother20034772082208712821450
- WalshALSmithMDWuthiekanunVImmunofluorescence microscopy for the rapid diagnosis of melioidosisJ Clin Pathol19944743773798027383
- PriceEPHornstraHMLimmathurotsakulDWithin-host evolution of Burkholderia pseudomallei in four cases of acute melioidosisPLoS Pathog201061e100072520090837
- LimmathurotsakulDWuthiekanunVChantratitaNSimultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosisJ Clin Microbiol200745113830383217804651
- HezardNCornilletPDroulleCGillotLPotronGNguyenPFactor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate positionThromb Res199788159669336874
- AmblerRPCoulsonAFFrereJMA standard numbering scheme for the class A β-lactamasesBiochem J1991276Pt 12692702039479
- GermerSHiguchiRSingle-tube genotyping without oligonucleotide probesGenome Res19999172789927486
- RhollDAPapp-WallaceKMTomarasAPVasilMLBonomoRASchweizerHPMolecular investigations of PenA-mediated β-lactam resistance in Burkholderia pseudomalleiFront Microbiol2011213921747814
- CurrieBJWardLChengACThe epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective studyPLoS Negl Trop Dis2010411e90021152057
- LimmathurotsakulDChaowagulWChantratitaNA simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosisPLoS Negl Trop Dis2008210e32718958279
- PearsonTU’RenJMSchuppJMVNTR analysis of selected outbreaks of Burkholderia pseudomallei in AustraliaInfect Genet Evol20077441642317258514
- HoldenMTTitballRWPeacockSJGenomic plasticity of the causative agent of melioidosis, Burkholderia pseudomalleiProc Natl Acad Sci U S A200410139142401424515377794